TY  - JOUR 
AU  - Maza Solano, Juan
AU  - Calvo Henríquez, Christian
AU  - Alobid, Isam
AU  - Álvarez Cendrero, Marta
AU  - Palomares, Óscar
AU  - Moreno Luna, Ramón
AU  - Santos Pérez, Jaime
AU  - González García, Jaime
AU  - Sánchez Gómez, Serafín
PY  - 2022
SN  - 2077-0383
UR  - https://uvadoc.uva.es/handle/10324/60263
AB  - Currently, some monoclonal antibodies (mAbs) are being studied for chronic rhinosinusitis with nasal polyps (CRSwNP). Three anti-IL-5 mAb: mepolizumab, reslizumab and benralizumab, have been tested through randomized clinical trials. In this real-life...
LA  - eng
PB  - MDPI
KW  - Asthma
KW  - Asma
KW  - Allergy
KW  - Otorhinolaryngology
KW  - Otorrinolaringologia
KW  - Chronic diseases
KW  - Enfermedades crónicas
KW  - Respiratory organs - Diseases
KW  - Respiratorio, aparato - Enfermedades
KW  - Pneumology
KW  - Neumología
KW  - Nose - Diseases
KW  - Nariz - Enfermedades
KW  - Asthma - Treatment
KW  - Asma - Tratamiento
TI  - Nasal symptoms in asthmatic patients under treatment with anti-IL-5 monoclonal antibodies. A real-life cohort study
DO  - 10.3390/jcm11237056
ER  -